Position in EXOZ
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$210,750
New position
Shares Held
25,000
first reported quarter
Ownership
0.269%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#2
of 10 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Davidson Kahn Capital Management, LLC holds $1,638,620 across 2 Biotechnology names. EXOZ ranks #2 (12.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IBRX |
ImmunityBio, Inc.
|
163,092 | $1,427,870 | |
| 2 | EXOZ |
Exozymes Inc.
This page
|
25,000 | $210,750 |
All Filings in EXOZ
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $210,750 | 25,000 | Shares | Sole | 2026-07-15 | |
| No filing history on record for this holder in this stock. | ||||||